67 related articles for article (PubMed ID: 6299173)
1. Changes in the protein composition of Epstein-Barr Virus-negative lymphoma cells after EBV-conversion.
Siegert W; Mönch T
Anticancer Res; 1983; 3(1):11-6. PubMed ID: 6299173
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.
Siegert W; Mönch T; Valet G
Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102
[TBL] [Abstract][Full Text] [Related]
3. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines.
Koide N; Wells A; Klein G; Ernberg I
Intervirology; 1981; 16(3):142-8. PubMed ID: 6277822
[TBL] [Abstract][Full Text] [Related]
4. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
5. Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublines.
Yefenof E; Lundin L; Klein G
Eur J Immunol; 1978 Mar; 8(3):190-3. PubMed ID: 207534
[TBL] [Abstract][Full Text] [Related]
6. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection is associated with increased apoptosis in untreated and phorbol ester-treated human Burkitt's lymphoma (AW-Ramos) cells.
Ishii HH; Gobé GC
Biochem Biophys Res Commun; 1993 May; 192(3):1415-23. PubMed ID: 8389551
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
Margalith M; Manor D; Cohen T
Cancer Biochem Biophys; 1983; 6(3):189-96. PubMed ID: 6303555
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Szekely L; Pokrovskaja K; Klein G
Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
[TBL] [Abstract][Full Text] [Related]
10. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
Leinbach SS; Summers WC
J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
[TBL] [Abstract][Full Text] [Related]
12. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
13. Possible DNA-RNA tumor virus interaction in human lymphomas: expression of retroviral proteins in Ramos lymphoma lines is enhanced after conversion with Epstein-Barr virus.
Lasky RD; Troy FA
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):33-7. PubMed ID: 6320170
[TBL] [Abstract][Full Text] [Related]
14. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
Berger R; Bernheim A
C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
[TBL] [Abstract][Full Text] [Related]
15. Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion.
Montagnier L; Gruest J
Int J Cancer; 1979 Jan; 23(1):71-5. PubMed ID: 215564
[TBL] [Abstract][Full Text] [Related]
16. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma.
Trivedi P; Zhang QJ; Chen F; Minarovits J; Ekman M; Biberfeld P; Klein G; Winberg G
Oncogene; 1995 Aug; 11(3):505-10. PubMed ID: 7630634
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
18. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
[TBL] [Abstract][Full Text] [Related]
19. Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines.
van Beek WP; Nilsson K; Klein G; Emmelot P
Int J Cancer; 1979 Apr; 23(4):464-73. PubMed ID: 220199
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
